Hrt Financial LP Halozyme Therapeutics, Inc. Transaction History

Hrt Financial LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$37.81 - $52.4 $346,150 - $479,722	9,155 New	9,155 $479,000
Q4 2023 Feb 09, 2024	SELL	$33.32 - $42.1 $120,485 - $152,233	-3,616 Reduced 4.41%	78,318 $2.89 Million
Q3 2023 Nov 13, 2023	BUY	$36.46 - $44.03 $1.83 Million - $2.21 Million	50,127 Added 157.6%	81,934 $3.13 Million
Q2 2023 Aug 11, 2023	SELL	$30.28 - $38.74 $1.27 Million - $1.62 Million	-41,822 Reduced 56.8%	31,807 $1.15 Million
Q1 2023 May 12, 2023	BUY	$32.86 - $55.7 $363,661 - $616,431	11,067 Added 17.69%	73,629 $2.81 Million
Q4 2022 Feb 10, 2023	BUY	$40.06 - $59.44 $1.8 Million - $2.66 Million	44,817 Added 252.56%	62,562 $3.56 Million
Q3 2022 Nov 14, 2022	SELL	$38.53 - $51.78 $2.34 Million - $3.14 Million	-60,629 Reduced 77.36%	17,745 $701,000
Q2 2022 Aug 12, 2022	BUY	$37.35 - $48.3 $2.93 Million - $3.79 Million	78,374 New	78,374 $3.45 Million
Q1 2022 May 16, 2022	SELL	$31.97 - $41.06 $1.14 Million - $1.46 Million	-35,547 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $1.13 Million - $1.45 Million	35,547 New	35,547 $1.43 Million
Q2 2021 Aug 16, 2021	SELL	$38.84 - $51.31 $819,213 - $1.08 Million	-21,092 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$39.51 - $51.45 $833,344 - $1.09 Million	21,092 New	21,092 $879,000
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $191,667 - $301,013	-13,789 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$14.93 - $19.53 $101,777 - $133,136	-6,817 Reduced 33.08%	13,789 $244,000
Q3 2019 Nov 14, 2019	BUY	$15.2 - $17.69 $313,211 - $364,520	20,606 New	20,606 $319,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.